2019 Neil Mackenzie Mentorship Excellence Award

The Neil Mackenzie Mentorship Excellence Award is given annually to a Centre for Blood Research (CBR) member in memory of Dr. Neil Mackenzie, a former postdoctoral fellow in Dr. Dieter Brömme’s lab. Dr. Mackenzie served as an outstanding mentor and inspired others with his enthusiasm, kindness, and selflessness. Since 2015, CBR has recognized individuals who demonstrated significant contributions and excellence in mentorship…
Read More
Eight of Simon Fraser University’s leading academic scholars have become the first to receive the prestigious title of Distinguished SFU Professor. This new designation recognizes their outstanding performance and achievements, and celebrates their international pre-eminence in their fields. The Distinguished SFU Professor title comes with a special requirement for members to share their work with the public through events such…
Read More
The authors found that type 1 T-regulatory (Tr1) cells have functions outside beyond their expected ability to regulate immune cells. Specifically, Tr1 cells secreted factors which could help promote the health of cells lining the intestinal epithelium. These unique properties of Tr1 cells could make them an ideal cell therapy to treat inflammatory diseases of the gut, such as Crohn’s disease and ulcerative colitis. The Levings lab is developing humanized mouse models to test the function of these cells in models of intestinal inflammation.
Read More
Nine BC health researchers have been funded in MSFHR’s third Innovation to Commercialization (I2C) competition. Each will receive funding to advance their medical treatments, diagnostic tools and assistive technologies towards practical application to improve health outcomes and enrich the health innovation ecosystem in BC. Now in its third year, the I2C Program is designed to help BC health researchers advance their discoveries or…
Read More

A Genetic Explanation for Lymphoma Patients That Cannot Be Cured by Standard Treatment

The most common form of non-Hodgkin lymphoma, known as diffuse large B-cell lymphoma (DLBCL), is considered a curable disease with the exception of a subset of patients for whom the standard treatment is not effective. But scientists at Canada’s Michael Smith Genome Sciences Centre (GSC) have uncovered a genetic explanation for why some patients have poor prognosis. Like all forms…
Read More
Model Organisms is the talk of the city as Vancouver Community College (VCC) and BC Children’s Hospital present their creative new collection at Vancouver Kids Fashion Week (VKFW) for the SS20 season. Model Organisms is the result of a collaboration between students, alumni, and instructors in VCC’s fashion design and production program as well as research scientists in the Healthy Starts theme at BC Children’s…
Read More
Metal pollution is a global issue often caused by activities such as mining and smelting operations, industrial production and use, and domestic and agricultural applications of metal-containing compounds. Water that flows through sites contaminated with metals can dissolve and transport toxic levels of metals such as copper, zinc, iron etc. into local waterways, which can be harmful to fish and…
Read More
The Canadian Nuclear Isotope Council (CNIC) has released a new report highlighting the need for strong Canadian leadership to ensure a domestic and international supply of medical isotopes. Patients fighting cancer and other medical conditions all over the world rely on Canada for a safe and stable supply of medical isotopes. This presents a major challenge – and opportunity –…
Read More
Solid tumors produce proteins that can induce the accumulation of bone marrow-derived cells in various tissues, and these cells can enhance metastatic tumor growth by several mechanisms. 4T1 murine mammary tumors are known to produce granulocyte colony-stimulating factor (G-CSF) and increase the numbers of immunosuppressive CD11b+Gr1+ myeloid-derived suppressor cells (MDSCs) in tissues such as the spleen and lungs of tumor-bearing mice.…
Read More
Canadian prostate cancer research leaders are receiving nearly $2 million to accelerate discoveries to save and improve men’s lives. Prostate Cancer Canada and Movember awarded the funds through the Discovery Grant program to support new and innovative research. “The future has never looked better for men with prostate cancer, but there is still work to do. We can’t stop as…
Read More